AGGRASTAT (Medicure International Inc)
Welcome to the PulseAid listing for the AGGRASTAT drug offered from Medicure International Inc. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Medicure International Inc |
| NON-PROPRIETARY NAME: | TIROFIBAN |
| SUBSTANCE NAME: | TIROFIBAN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-10-15 |
| END MARKETING DATE: | 0000-00-00 |
AGGRASTAT HUMAN PRESCRIPTION DRUG Details:
| Item Description | AGGRASTAT from Medicure International Inc |
| LABELER NAME: | Medicure International Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.75(mg/15mL) |
| START MARKETING DATE: | 2016-10-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25208-001_72519bff-80d2-4090-b123-d94df56b1512 |
| PRODUCT NDC: | 25208-001 |
| APPLICATION NUMBER: | NDA020912 |
Other TIROFIBAN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
